Author Archives: lyndenend
Gradian II: Marketing to Multiple Stakeholders in a Complicated Field
This post explores how Gradian Health Systems is tackling the challenge of marketing its Universal Anaesthesia Machine to four distinct but interconnected stakeholder groups: users, hospitals, Ministries of Health, and donor organizations. It was written by Julie Manriquez, Lyn Denend, … Continue reading
Gradian I: Spinning Out a Commercial Entity from a Nonprofit Foundation
This post describes the unique arrangement Dr. Paul Fenton entered into with The Nick Simons Foundation to establish a commercial entity to bring his Universal Anaesthesia Machine to market. It also explores the hybrid business model the new company—known as … Continue reading
The East Meets West Foundation: Expanding Organizational Capacity
This post describes how the East Meets West Foundation helped its overseas partner expand its engineering and manufacturing capabilities as it pursued the need for an infant phototherapy solution designed to meet the requirements of low resource environments. It was … Continue reading
DoseRight II: Transitioning to High-Volume Production
This entry tells the story of how 3rd Stone Design took a working prototype for a new medical technology developed at Rice University and prepared it for high-volume manufacturing on its way to market. It was written by Lyn Denend and … Continue reading
DoseRight I: Moving Out of the Lab
This post describes how 3rd Stone Design partnered with Rice University to effectively move a promising medical technology out of the lab and into the market. It was authored by Lyn Denend and Professor Stefanos Zenios of the Stanford GSB’s Program in … Continue reading
The JaipurKnee Project II – Scaling Up the Business
This post describes how the JaipurKnee team—now ReMotion Designs—defined a business strategy to scale up the dissemination of its product under challenging circumstances. It was authored by Lyn Denend and Professor Stefanos Zenios of the Stanford GSB’s Program in Healthcare Innovation.
SafePoint II – Sustaining Adoption
This story explores how the SafePoint Trust proactively sought to align stakeholders around the adoption of auto disable syringes in Tanzania to help ensure that uptake would be widespread and sustainable. Continue reading
SafePoint I – Stimulating Adoption
This story describes how the SafePoint Trust used public awareness to stimulate the adoption of auto disable syringes when it realized that uptake was stalled due to stakeholder resistance. Continue reading
